The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 24-32 , January 2003

Mast cells: Beyond IgE

Received 7 October 2002 ,Accepted 16 October 2002.

  • Image Result

    Constitutive versus reactive tissue mast cell development on the basis of the prototype of the intestine. Basal homing of blood-borne committed mast cell progenitors (PrMC) depends on the intact funct

    Constitutive versus reactive tissue mast cell development on the basis of the prototype of the intestine. Basal homing of blood-borne committed mast cell progenitors (PrMC) depends on the intact function of the β7 integrin subunit forming a heterodimer with the α4 integrin subunit that interacts with mucosal adressin cell adhesion molecule 1 (MadCAM1) and vascular cell adhesion molecule 1 (VCAM1) . Differentiation of all mast cells requires the input of SCF and its receptor, c-kit. Development of the reactive subtype, observed in the epithelial compartment in mucosal inflammation, requires additional cytokines derived from activated T cells. The subtypes differ in protease content and effector profile. CPA, Carboxypeptidase A.

  • Image Result
    Constitutive versus reactive tissue mast cell development on the basis of the prototype of the intestine. Basal homing of blood-borne committed mast cell progenitors (PrMC) depends on the intact funct

    Constitutive versus reactive tissue mast cell development on the basis of the prototype of the intestine. Basal homing of blood-borne committed mast cell progenitors (PrMC) depends on the intact function of the β7 integrin subunit forming a heterodimer with the α4 integrin subunit that interacts with mucosal adressin cell adhesion molecule 1 (MadCAM1) and vascular cell adhesion molecule 1 (VCAM1) . Differentiation of all mast cells requires the input of SCF and its receptor, c-kit. Development of the reactive subtype, observed in the epithelial compartment in mucosal inflammation, requires additional cytokines derived from activated T cells. The subtypes differ in protease content and effector profile. CPA, Carboxypeptidase A.

  • Image Result
    Regulatory effects of IL-4 on biosynthesis and reception of cysLTs by mast cells. Human mast cells express the CysLT1 receptor constitutively, which transduces a calcium flux to both cysLTs and UDP. W

    Regulatory effects of IL-4 on biosynthesis and reception of cysLTs by mast cells. Human mast cells express the CysLT1 receptor constitutively, which transduces a calcium flux to both cysLTs and UDP. With IL-4 priming, both LTC4 and UDP elicit mast cell activation at 3 log-fold lower doses and elicit cytokine generation through a nuclear factor of activated T cells– and extracellular regulated kinase–dependent pathway, without exocytosis. The priming effect occurs without changes in CysLT1 receptor expression. IL-4 priming also upregulates FcϵRI-dependent generation of cysLTs by inducing LTC4S expression. Autocrine actions of cysLTs are indicated by partial antagonism of FcϵRI-dependent cytokine generation by the CysLT1 receptor selective antagonist MK571 and by MK886, a biosynthetic inhibitor. MIP, Macrophage inflammatory protein.

  • Image Result
    Hypothetic consequences of non–IgE-dependent activation of constitutive and reactive mast cell phenotypes. Under baseline conditions, mast cell activation by microbes, toxins, and humoral factors elic

    Hypothetic consequences of non–IgE-dependent activation of constitutive and reactive mast cell phenotypes. Under baseline conditions, mast cell activation by microbes, toxins, and humoral factors elicits neutrophil recruitment, contains invasive pathogens, and facilitates tissue healing. Under conditions of T-cell priming (particularly IL-4) in asthma and allergic diseases, the same activating stimuli produce an amplified mast cell response, resulting in sustained inflammation, tissue dysfunction, and remodeling.

 Supported by National Institutes of Health grants AI31599, HL36110, AI48802, and AI52353 and by grants from the Charles Dana Foundation and the Vinik Family Fund for Research in Allergic Diseases in Children.

☆☆ Reprint requests: Joshua A. Boyce, MD, Harvard Medical School, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Smith Research Building, Room 626, 1 Jimmy Fund Way, Boston, MA 02199.

PII: S0091-6749(02)91322-9

doi: 10.1067/mai.2003.60

The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 24-32 , January 2003